TELO2 and central nervous system cancer: Our previous study demonstrated that human high-grade gliomas show increased TELO2 mRNA expression and that the overexpression of TELO2 mRNA correlates with shorter survival outcomes, suggesting that TELO2 is an oncogene in human gliomas [16].